Tag:

ICON

Latest Headlines

Latest Headlines

Icon gets in on the ground floor with a Novartis-backed biotech upstart

Irish CRO Icon has signed on to be the exclusive service provider for a new U.K. biotech startup, planning to help the nascent company advance a trio of Novartis-developed drugs.

Icon dials back its guidance after posting modest sales growth

Icon is again reducing its revenue expectations for 2015 but increasing its profit guidance, counting on a big quarter of business wins to balance some sluggish backlog conversion.

Icon and Covance bet on diagnostics with a pair of cancer deals

CROs Icon and Covance signed a pair of separate partnerships in the world of cancer diagnostics, each betting that new technologies in oncology testing will increase global demand.

Icon rolls out some new patient-consent tech with a focus on education

Icon, at work on new approaches to educating potential study participants, launched a new technology designed to inform patients of the possible risks and benefits of a clinical trial before they meet with a physician.

Icon dampens its outlook despite a strong quarter

Icon came through with double-digit revenue growth in the first quarter, but currency fluctuations have the Irish CRO scaling back its expectations for the full year.

Icon taps Carnegie Mellon to help patients better understand trials

When patients sign up for a clinical trial, how well do they understand the risks, requirements and restrictions that come with it? Icon, a global CRO that handles thousands of studies a year, is working with behavioral scientists at Carnegie Mellon University to study how investigators can improve the informed consent process.

Icon doubles down on med tech with latest offering

Global CRO Icon is launching a new service catered to the specific needs of medical device and diagnostic developers, touting one of its recent acquisitions as key to the move.

Icon rides a revenue leap into another growth year

CRO giant Icon dialed up its fourth-quarter revenue on the way to a big year, forecasting another leap in 2015.

Icon buys a market-access firm for $120M

Irish CRO Icon is expanding its drug launch and marketing services, trading $120 million in cash for MediMedia Pharma Solutions.

Icon is adding 200 jobs with a new Irish R&D outpost

Irish CRO Icon is plotting a new so-called innovation hub in its native Ireland, planning to hire 200 workers as it builds out a data-minded expansion.